CHLOE WILLIAMS: Open Payments
NPI 1245899533 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,491 in 126 payments from 35 companies in 2025. Trend: 2023 $538 · 2024 $1,600 · 2025 $2,491
Food & beverage: $2,424Education: $67
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $397 |
| Novo Nordisk Inc | 11 | $225 |
| Lilly USA, LLC | 9 | $167 |
| GlaxoSmithKline, LLC. | 7 | $144 |
| Amgen Inc. | 13 | $139 |
| Genentech USA, Inc. | 4 | $118 |
| JAZZ PHARMACEUTICALS INC. | 3 | $118 |
| PFIZER INC. | 4 | $85 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $84 |
| TG Therapeutics, Inc. | 3 | $71 |
Products named: QULIPTA, Ocrevus Zunovo, TRELEGY ELLIPTA, UBRELVY, MOUNJARO, VYALEV, JARDIANCE, XYWAV.
Industry payments across TX — which companies pay providers there.
